![]() |
|||||
| company | services | news | technology | contact | |
A c c e l e r a t o r M a s s S p e c t r o m e t r yResearch Services for Drug Development |
| ||||
New Press Release ... Data from a human micro-dose trial, produced by Vitalea Science, Inc. using Accelerator Mass Spectrometry (AMS) technology, demonstrated that RDEA436, a MEK inhibitors has a long half-life and favorable PK parameters ... New Publications Use of Accelerator Mass Spectrometry to measure the Pharmacokinetics and... Methods and applications of HPLC-AMS ... Disposition of 14C-b-carotene following delivery with autologous triacylglyceride-rich lipoproteins... ©2007 Vitalea Science, Inc. |
Welcome to Vitalea Science Vitalea Science is a pioneering Bioanalytical Contract Research Organization, which provides services supported by new Accelerator Mass Spectrometry technologies for exploring the pharmacokinetics and metabolism of drug candidates directly in humans, both prior to and as part of Phase I clinical trials. These avenues can accelerate a compound or class of compounds or biologics through the development process by revealing the true human metabolism and physiochemistry, without reliance on extrapolation from often-irrelevant animal models or on human cellular assays that lack the full metabolism and target complement of a living person. “Accelerating early clinical development with microdosing and microtracers” enables more effective development decisions, increasing potential success while reducing costs of failure for new drugs, formulations and delivery strategies. We are partnered with several clinics in many countries to offer innovative clinical options to your drug development program. Please visit Our Partners for more information. We welcome the opportunity to work with you! |
||||

